Effect of Preoperative Mitral Regurgitation on LVAD Outcomes in Patients with Elevated Pulmonary Vascular Resistance
Authors:
- Riyad Yazan KherallahRKRiyad Yazan Kherallah
- Harveen K. LambaHLHarveen K. Lamba
- Andrew B. CivitelloACAndrew B. Civitello
- Ajith P. NairANAjith P. Nair
- Leo SimpsonLSLeo Simpson
- Alexis E. ShafiiASAlexis E. Shafii
- Gabriel LoorGLGabriel Loor
- Joggy K. GeorgeJGJoggy K. George
- Reynolds M. DelgadoRDReynolds M. Delgado
- Kenneth K. LiaoKLKenneth K. Liao
- Raymond F. StainbackRSRaymond F. Stainback
- O. H. FrazierOFO. H. Frazier
- 20 August 2024
- journal article
- research article
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 39 (5) , 1085-1095
Abstract
Purpose In patients with end-stage heart failure who undergo left ventricular assist device (LVAD) implantation, higher pulmonary vascular resistance (PVR) is associated with higher right heart failure rates and ineligibility for heart transplant. Concomitant mitral regurgitation (MR) could potentially worsen pulmonary hemodynamics and lead to worse outcomes; however, its effects in this patient population have not been specifically examined. Methods Using an institutional database spanning November 2003 to August 2017, we retrospectively identified patients with elevated PVR who underwent LVAD implantation. Patients were stratified by concurrent MR: moderate/severe (PVR + MR) vs. mild/none (PVR − MR). Cumulative incidence functions and Fine-Gray competing risk regression were performed to assess the effect of MR on heart transplant rates and overall survival during index LVAD support. Results Of 644 LVAD recipients, 232 (171 HeartMate II, 59 HeartWare, 2 HeartMate III) had baseline PVR > 3 Woods units; of these, 124 (53%) were INTERMACS 1–2, and 133 (57%) had moderate/severe MR (≥ 3 +). Patients with PVR + MR had larger a baseline left ventricular end-diastolic diameter than patients with PVR − MR (87.9 ± 38.2 mm vs. 75.9 ± 38.0 mm; P = 0.02). Median clinical follow-up was 18.8 months (interquartile range: 4.7–36.4 months). Moderate/severe MR was associated with lower mortality rates during index LVAD support (adjusted hazard ratio 0.64, 95% CI 0.41–0.98; P = 0.045) and higher heart transplant rates (adjusted odds ratio 2.86, 95% CI 1.31–6.25; P = 0.009). No differences in stroke, gastrointestinal bleeding, or right heart failure rates were observed. Conclusions Among LVAD recipients with elevated preoperative PVR, those with moderate/severe MR had better overall survival and higher transplant rates than those with mild/no MR. These hypothesis-generating findings could be explained by incremental LVAD benefits resulting from reduction of MR and better LV unloading in a subset of patients with larger ventricles at baseline. In patients with preoperative elevated PVR, MR severity may be a prognostic sign that can inform patient selection for end-stage heart failure therapy. Graphical AbstractKeywords
This publication has 24 references indexed in Scilit:
- Survival Analysis in the Presence of Competing Risks: The Example of Waitlisted Kidney Transplant CandidatesAmerican Journal of Transplantation, 2016
- Introduction to the Analysis of Survival Data in the Presence of Competing RisksCirculation, 2016
- The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year updateThe Journal of Heart and Lung Transplantation, 2016
- Effect of pulmonary vascular resistance before left ventricular assist device implantation on short- and long-term post-transplant survivalThe Journal of Thoracic and Cardiovascular Surgery, 2015
- High pulmonary vascular resistance in addition to low right ventricular stroke work index effectively predicts biventricular assist device requirementJournal of Artificial Organs, 2015
- Uncorrected pre-operative mitral valve regurgitation is not associated with adverse outcomes after continuous-flow left ventricular assist device implantationThe Journal of Heart and Lung Transplantation, 2015
- Prognostic value of the pre-transplant diastolic pulmonary artery pressure–to–pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertensionThe Journal of Heart and Lung Transplantation, 2014
- 2013 ACCF/AHA Guideline for the Management of Heart FailureJACC, 2013
- Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipientsEuropean Journal of Cardio-Thoracic Surgery, 2011
- Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiographyJournal of the American Society of Echocardiography, 2003